When $1.2 billion chemicals distributor Redox went public in July, chief executive Raimond Coneliano toasted the $400 million-plus listing with lunch at subterranean Sydney staple Bistecca.
For Coneliano, lunch with his team of UBS advisers at the Florentine-inspired steak house capped off the “out-of-body experience” he described of listing his family-run business.
Aaron WeinmanCorrespondentAaron Weinman is a correspondent at The Australian Financial Review who covers investment banks, private equity firms and the broader capital markets. Connect with Aaron on Twitter. Email Aaron at aaron.weinman@afr.com
Jemima WhyteSenior reporterJemima Whyte writes on business, specialising in companies, capital markets and innovation. Jemima has reported on business for The Australian Financial Review for more than 13 years. Email Jemima at jemima.whyte@afr.com
